옵션 체인은 다양한 행사가격과 만기일에 대한 Ginkgo Bioworks Holdings의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Ginkgo Bioworks Holdings에 대한 시장 심리를 평가합니다..

Ginkgo Bioworks Holdings (NYSE:DNA) 주식, 옵션 체인

Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.

Equities

News

Markets

ETFs

ACHR

ARKK

AVAV

BLDE

NTLA

TDOC

TSLA

VERV

수요일에 캐시 우드가 이끄는 아크 인베스트(Ark Invest)는 이 회사의 인상적인 2분기 납품 실적에 힘입은 최근 상승세에도 불구하고 테슬라(NASDAQ:TSLA)의 상당 수의 주식을 매각하여 주목할만한 움직임을 보였다.

아크 인베스트가 예상을 넘는 2분기 배송 실적에도 $3.25백만 규모 테슬라 주식 매도 추가

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

ARKW

COIN

ROKU

수요일에 캐시 우드가 주도하는 아크 인베스트(Ark Invest)는 변동성이 큰 시장 속에서 로쿠(NASDAQ:ROKU)와 코인베이스 글로벌(NASDAQ:COIN)에서 상당한 거래를 했다. 이러한 눈에 띄는 거래는 아크의 다양한 ETF가 수행한 일련의 거래의 일부였다.
로쿠 거래

아크 인베스트는 로쿠 $730만의 주식을 매수, 비트코인 하락에 코인베이스 주식을 매각

ARCT

ARKQ

MKFG

NVDA

2024년 6월 25일 화요일, 캐시 우드가 주도하는 아크 인베스트(Ark Invest)는 상당한 시장 변동성 속에서 엔비디아(NASDAQ:NVDA)와 로쿠(NASDAQ:ROKU)에서 상당한 거래를 했다. 이러한 거래는 아크의 다양한 ETF가 이행한 일련의 거래의 일부였다.

아크 인베스트는 주가 반등 속에 엔비디아 주식에서 $430만 매도, 로쿠 주식을 매수

Ginkgo Bioworks Holdings, Inc. Class A Common Stock

Ginkgo Bioworks Holdings Inc

Metaverse Dualchain Network Architecture

DeNA Co Ltd

DNAPRINT GENOMICS INC by DNAPrint Genomics, Inc.

DNA Print Genomics Inc

DNA Brands Inc

WIIM

GameStop shares are trading higher. Retail trader 'Roaring Kitty' posted a picture of a Christmas present on X.

Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) could ride the artificial intelligence boom, with its crown jewel iPhone expected to witness a "multi-year" upgrade cycle, according to an analyst.
What Happened: Tech bull and Wedbush analyst Dan Ives believes that Apple's iPhone sales could witness a boost thanks to AI.
"Raising price target on Apple to $325 as a golden era of growth for Cupertino is now on the horizon into 2025," said Ives in a post on X.
Apple stock closed at $258.20 on Tuesday, up 1.2% for the day. Year-to-date, Apple shares have gained 39%, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>. Ives&#8217; $325 price target implies a 26% upside.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/AAPL/analyst-ratings"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26081608/Screenshot-2024-12-26-at-6.46.00%E2%80%AFPM-1024x385.png" alt="" class="wp-image-707606" /></a></figure>
While Apple has been a little late to the AI game, having been beaten by its rivals Alphabet Inc.'s Google, and Samsung Electronics Co. Ltd., <a href="https://www.benzinga.com/news/24/09/40780100/apple-intelligence-ready-iphone-16-with-faster-processor-dedicated-camera-button-announced-check-pri">the Cupertino-based company unveiled</a> the Apple Intelligence suite of AI features with the iPhone 16 series in September.
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
Ives expects Apple to benefit significantly from the consumer AI revolution, positioning it for substantial growth through 2025.
"We believe Apple is heading into a multi-year AI driven iPhone upgrade cycle still being underestimated by the Street."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Raising price target on Apple to $325 as a golden era of growth for Cupertino is now on the horizon into 2025. We believe Apple is heading into a multi-year AI driven iPhone upgrade cycle still being underestimated by the Street. The consumer AI Revolution goes thru &#x1f34e; &#x1f525;&#x1f402;&#x1f34e;&#x1f34f;
&mdash; Dan Ives (@DivesTech) <a href="https://twitter.com/DivesTech/status/1872250576370913362?ref_src=twsrc%5Etfw">December 26, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/tech/24/12/42641667/is-this-nancy-pelosis-stock-pick-set-to-overtake-nvidia-ai-chip-race-to-heat-up-by-2025-as-meta-and-microsoft-look-beyond-jensen-huangs-chip-maker-says-expert?itm_source=parsely-api">Is This Nancy Pelosi&#8217;s Stock Pick Set To Overtake Nvidia?</a>
Why It Matters: The recent price target hike aligns with <a href="https://www.benzinga.com/markets/equities/24/12/42664887/apples-near-term-success-will-be-driven-by-strong-holiday-season-iphone-16-says-dan-ives-analyst-sees-stock-hitting-300-cupertino-hitting-4-trillion-marketcap">Ives' previous predictions</a>, which foresees Apple reaching a $4 trillion market capitalization by early 2025. This projection is driven by strong iPhone sales and AI innovations.
Recent supply chain checks in Asia indicate robust iPhone 16 upgrade trends, particularly during the holiday season. Ives believes that the success of the iPhone 16 will serve as a launchpad for a renaissance of growth in Cupertino over the next 12 to 18 months.
Furthermore, <a href="https://www.benzinga.com/markets/equities/24/12/42477035/dan-ives-predicts-apple-to-ship-record-240-million-iphones-in-2025-sparking-multi-year-supercycle-as-ai-integration-drives-growth">Ives predicts</a> that Apple will ship a record 240 million iPhones in 2025, setting a new annual record as AI features in the iPhone 16 spark a &#8220;multi-year supercycle.&#8221; This projection underscores the significance of AI integration in consumer devices, with Apple Inc. leading the charge.
Check out more of Benzinga's Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/24/12/42642020/steve-ballmers-bold-investment-strategy-80-of-his-portfolio-is-in-microsoft-stock-heres-why-his-keep-it-simple-approach-is-winning-big?itm_source=parsely-api">Steve Ballmer&#8217;s Winning Investment Strategy: Billionaire Says &#8216;Keep It Simple&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Pexels

Analyst Color

Price Target

Tech

AAPL

Tech Bull Predicts 26% Upside For Apple Stock, Sees 'Golden Era Of Growth' For Cupertino Due To Multi-Year AI-Driven iPhone Upgrade Cycle

CHEK

Check-Cap Approves $6M Loan To Nobul AI From Segregated Account At 5% Annual Interest To Support Acquisition Targets And Growth Initiatives, With Repayment Linked To Business Combination Outcome

COEP

Coeptis Therapeutics Acquires NexGenAI Affiliates Network Platform And Launches Coeptis Technologies To Drive AI Innovation In Biotech And Technology, Expanding Growth Potential With Advanced Marketing And Automation Tools

TScan Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCRX#NASDAQ">TCRX</a>) shares are trading higher in the <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42681377/tscan-therapeutics-announces-30-million-registered-direct-offering-at-a-37-premium" rel="noreferrer noopener">premarket session on Thursday.</a>
The firm announced a significant financing deal, entering into a securities purchase agreement with Lynx1 Capital Management LP and an investment fund advised by Lynx1.
Under the agreement, TScan will sell approximately $30 million in pre-funded warrants, which are exercisable for up to 7.50 million shares of its voting common stock.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, TCRX stock has lost over 51% in the past year.&nbsp;
Each warrant will be priced at $4.00, with an exercise price of $0.0001 per share.
This deal represents a 37% premium over TScan&#8217;s last closing price and a 34% premium compared to its 10-day volume-weighted average closing price. The financing is expected to close by December 27, 2024, pending customary closing conditions.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/12/42681352/us-futures-tumble-after-christmas-break-but-analysts-still-expect-a-santa-claus-rally" rel="noreferrer noopener">US Stocks Likely To Open In Red After Christmas Break But Analysts Still Expect A Santa Rally Into The New Year</a>
Gavin MacBeath, Ph.D., CEO of TScan Therapeutics, expressed appreciation for Lynx1&#8217;s continued support, highlighting the investment as a testament to their commitment to TScan&#8217;s mission of delivering life-changing TCR-T cell therapies for cancer patients.
Jason A. Amello, CFO of TScan, added that the additional $30 million in gross proceeds will extend the company&#8217;s cash runway, now expected to fund operations into the first quarter of 2027, up from the previous expectation of the fourth quarter of 2026.
This funding comes after TScan filed a registration statement with the SEC in November 2022, which was declared effective in May 2023.
Price Action: TCRX shares are trading higher by 16.8% to $3.40 premarket at last check Thursday.
Read Next:&nbsp;<a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42678014/top-7-blue-chip-stocks-with-the-best-return-potential-going-into-2025" rel="noreferrer noopener">S&amp;P 500 Hits 57 All-Time Highs In Record-Breaking 2024: Magnificent 7 Drive 30% Of Nasdaq's Surge</a>
Photo via Shutterstock.

Health Care

Offerings

Movers

General

TCRX

Why Is TScan Therapeutics Stock Gaining Today?

WISA

WiSA Technologies Signs Definitive Agreement To Acquire CompuSystems, Anticipating $13M-$15M Revenue And $3M-$4M EBITDA In 2025; Acquisition Enhances Event Data Monetization And Activates ADIO Technology For 1.4M Attendees; Conference Call Scheduled For December 30, 2024, At 11 AM ET; Financial Terms Not Disclosed

Despite bearish price action, Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) has seen a significant uptick in whale activity, fueling speculation of <a href="https://www.benzinga.com/money/dogecoin-doge-price-prediction">an impending bullish phase</a> among traders.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.3167&nbsp;</td>
<td>$46.7 Billion</td>
<td>-4.2%&nbsp;</td>
<td>-12.6%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00002171</td>
<td>$12.8 Billion</td>
<td>-5.4%</td>
<td>-9.7%&nbsp;</td>
</tr>
<tr>
<td>Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>)</td>
<td>$0.00001738  </td>
<td>$7.3 billion</td>
<td>-6.9%&nbsp;</td>
<td>-9.3%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Javon Marks <a href="https://x.com/JavonTM1/status/1871995033685311804">highlighted</a> historical patterns, suggesting Dogecoin could rise beyond the 1.618 Fibonacci Extension level, as it has in previous cycles. If this scenario repeats, DOGE could surge by 570%, reaching $2.28 or higher.
Crowtrades remains confident, declaring &#8220;$1 is a promise.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Dogecoin to $1 ain&#39;t a meme, it&#39;s a promise.<a href="https://twitter.com/search?q=%24DOGE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$DOGE</a> <a href="https://t.co/gpgMnwQEwZ">https://t.co/gpgMnwQEwZ</a> <a href="https://t.co/vy2JAwG8Bu">pic.twitter.com/vy2JAwG8Bu</a>
&mdash; CROW (@TheCrowtrades) <a href="https://twitter.com/TheCrowtrades/status/1871824957715681664?ref_src=twsrc%5Etfw">December 25, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Trader Tardigrade, another trader, <a href="https://x.com/TATrader_Alan/status/1871823205708738568">observed</a> consolidation patterns similar to those preceding Dogecoin's January 2021 pump. He predicts that January 2025 could mark another explosive breakout.
Statistics: Coinglass data shows Dogecoin's short liquidations of $845,000 are the lowest since Oct. 25.
Crypto chart analyst Ali Martinez <a href="https://x.com/ali_charts/status/1871651560540762452">noted</a> in a post on X on Wednesday that whales purchased 270 million DOGE over the past four days. This raises curiosity among traders if significant whale movement implies an upcoming bull run for the meme coin.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42645811/dogecoin-shiba-inu-could-underperform-stronger-cryptos-trader-warns-heres-why">Dogecoin, Shiba Inu Could Underperform Stronger Cryptos, Trader Warns: Here&#8217;s Why</a></li>
</ul>
Image: Shutterstock

$DOGE

$PEPE

$SHIB

Dogecoin Price Down 4%: What Is Going On?

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">84.69</td>
<td align="right">0.05</td>
<td align="right">0.05</td>
<td>4.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">134.20</td>
<td align="right">0.04</td>
<td align="right">0.02</td>
<td>295</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">97.88</td>
<td align="right">-1.29</td>
<td align="right">-1.31</td>
<td>526</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">79.09</td>
<td align="right">-0.35</td>
<td align="right">-0.45</td>
<td>2.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">76.18</td>
<td align="right">-0.30</td>
<td align="right">-0.40</td>
<td>1.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">138.83</td>
<td align="right">-0.49</td>
<td align="right">-0.36</td>
<td>1.0K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">239.68</td>
<td align="right">-0.85</td>
<td align="right">-0.36</td>
<td>3.1K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">48.86</td>
<td align="right">-0.13</td>
<td align="right">-0.27</td>
<td>16.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">234.36</td>
<td align="right">-0.11</td>
<td align="right">-0.05</td>
<td>180</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alert provides traders with a compiled way to read macro-level market trends. Investors garner a particular interest in sector movers to better determine sectors that are over- or under-performing to make better investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. 
For more information on sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For December 26, 2024

Toyota shares are trading higher following a recent report suggesting the company is seeking a 20% return-on-equity target. The stock may also be reacting to the Nissan-Honda merger agreement.

Biotech

ASMB

Assembly Biosciences Reports Interim Phase 1b Results From Trial Evaluating ABI-4334 In Chronic Hepatitis B; Says ABI-4334 Was Well Tolerated And Showed Mean Reduction Of 2.9 log IU/mL In Plasma HBV DNA Over 28 Days Of Treatment

Delivering 5x Power Efficiency Boost For AI And Blockchain, Showcasing Innovation In High-Performance Energy-Efficient Solutions

Nano Labs Unveils FPU3.0 ASIC Architecture With 3D DRAM Stacking

The reverse stock split will become effective at 12:01 a.m. Eastern Time on Monday, December 30, 2024, and the Company's common stock will commence trading on the Nasdaq on a post-split basis at the opening of the market on December 30, 2024, pending confirmation by the Depository Trust Company and the Nasdaq.&nbsp;
The Company expects that the reverse stock split, which was approved by the Company's stockholders on November 27, 2024, will increase the price per share of the Company's common stock, and is part of the Company's strategy to regain compliance with the $1.00 minimum bid price requirement of the Nasdaq.
 &nbsp;

Stock Split

JNVR

Janover Plans To Effect 1-For-8 Reverse Stock Split Of Its Common Stock

Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) <a href="https://www.benzinga.com/24/12/42657620/amd-and-micron-top-analyst-picks-for-ai-and-next-gen-tech-growth">shares</a> have underperformed Nasdaq 100 despite gaining AI market share this year. Should you buy or sell the stock as its technical analysis indicates a downtrend? Here&#8217;s what analysts are saying about the stock. 
What Happened: The technical analysis of daily moving averages indicates a bearish trend.
The stock ended at $126.29 apiece on Tuesday. This was above its eight-day simple moving average of $123.48. However, as per <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data, its current stock price was lower than the 20-day moving average of $130.77, 50-day moving average of $140.38 and its 200-day moving average of $154.50.
This implies that the stock is in a downtrend. On the other hand, the relative strength index of 40.31 suggests the stock&#8217;s movement is neutral and it is not yet in an overbought or an oversold zone.
<figure class="wp-block-image size-large"><a href="pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26071556/amd-chart-1024x576.png" alt="" class="wp-image-707497" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26071556/amd-chart-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26071556/amd-chart-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26071556/amd-chart-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26071556/amd-chart-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26071556/amd-chart.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
See Also: <a href="https://www.benzinga.com/general/market-summary/24/12/42680125/nvda-could-go-up-to-170-in-q1-after-breaching-145-level-as-traders-turn-bullish-on-jensen-huangs-ai-giant">NVDA Could Go Up To $170 In Q1 After Breaching $145 Level As Traders Turn Bullish On Jensen Huang&#8217;s AI Giant </a>
Why It Matters: AMD&#8217;s 2024 was mixed. New GPUs drove strong data center growth, gaining share against Nvidia&#8217;s H100 due to availability and pricing advantages. However, gaming and embedded segments decelerated, impacting overall growth.
According to <a href="https://www.benzinga.com/quote/AMD/analyst-ratings">Benzinga</a>, AMD has a consensus &#8216;buy&#8217; with a price target of $195.07 based on the ratings of 30 analysts.
The highest price target out of all the analysts <a href="https://www.benzinga.com/quote/AMD/analyst-ratings">tracked </a>by Benzinga is $265 issued by Melius Research with a &#8216;buy&#8217; rating on March 8. According to the analysts at Melius, AMD is mirroring Nvidia Corporation&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) past success. This is despite a recent price target increase, expected by market observers. While AMD&#8217;s growth is significant, it&#8217;s not seen as threatening Nvidia&#8217;s dominance. Nvidia&#8217;s broader ecosystem and market expansion benefit AMD by creating a larger market for high-performance AI chips.
AMD is one of <a href="https://www.benzinga.com/24/12/42657620/amd-and-micron-top-analyst-picks-for-ai-and-next-gen-tech-growth">Rosenblatt</a>'s top picks for the first half of 2025 on momentum in CPU and GPU share gains into 2025 and a broader non-AI recovery exiting 2025. The difference entering 2025 is that the Street acknowledges this dynamic, which has legs for double-digit market share in GPU compute and AI inference at the edge, being a secular opportunity on Xilinx incumbency and chiplet prowess.
The lowest target price was a downgrade from &#8216;buy&#8217; to &#8216;neutral&#8217; from BofA Securities. It was adjusted to $155 from $180 per share on Dec. 9. It predicts AMD will hold a small 4% of the $200 billion AI accelerator market in 2025, significantly trailing Nvidia&#8217;s dominant 80%+ share. This, coupled with potential PC processor market weakness in the first half of 2025, raises concerns for AMD&#8217;s future performance.
The average price target of $164.33 between Morgan Stanley, BofA Securities, and Mizuho implies a 30.81% upside for Nvidia.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/AMD/analyst-ratings"><img loading="lazy" decoding="async" width="943" height="361" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26071348/AMD-ANR-.png" alt="" class="wp-image-707495" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26071348/AMD-ANR-.png 943w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26071348/AMD-ANR--300x115.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26071348/AMD-ANR--768x294.png 768w" sizes="(max-width: 943px) 100vw, 943px" /></a></figure>
Price Action: Shares of AMD were down 0.24% at $125.99 per share in premarket on Thursday. The stock was down 8.87% this year underperforming the Nasdaq 100, which rose by 31.76% this year.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42678014/top-7-blue-chip-stocks-with-the-best-return-potential-going-into-2025">S&amp;P 500 Hits 57 All-Time Highs In Record-Breaking 2024: Magnificent 7 Drive 30% Of Nasdaq&#8217;s Surge</a></li>
</ul>
Image via Shutterstock

Downgrades

Technicals

Reiteration

Analyst Ratings

Trading Ideas

Should You Buy or Sell This Nvidia Rival? Analysts Weigh In As Technicals Signal A Downtrend

Welltower's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>) short percent of float has fallen 5.38% since its last report. The company recently reported that it has 10.09 million shares sold short, which is 2.11% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.9 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Welltower Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735218024_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Welltower has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Welltower's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Welltower's peer group average for short interest as a percentage of float is 7.65%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

WELL

Looking Into Welltower's Recent Short Interest

Glaukos's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GKOS#NYSE">GKOS</a>) short percent of float has fallen 3.61% since its last report. The company recently reported that it has 2.57 million shares sold short, which is 7.47% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.63 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Glaukos Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735218018_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Glaukos has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Glaukos's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Glaukos's peer group average for short interest as a percentage of float is 3.70%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

GKOS

(GKOS) - Analyzing Glaukos's Short Interest

According to a report issued by Realtor.com, counties switching their presidential votes from Biden to Trump in 2024 might see accelerated home price growth over the next four years.
The report, drawn from a study by the Journal of Real Estate Research, examined home prices and presidential election results across six elections from 2000 to 2020. Data showed that flipping to successful nonincumbent candidates <a href="https://www.benzinga.com/real-estate/24/11/41747603/30-less-than-blue-swing-state-home-prices-align-with-red-states-says-realtor-com">outperformed other markets in home value appreciation</a>.
Realtor identified 84 counties nationwide that shifted from Biden in 2020 to Trump in 2024, ranging from Florida&#8217;s Miami-Dade County to Montana&#8217;s Blaine County along the Canadian border.
Don't Miss:
<ul>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/go/arrived-private-credit-yf">7-9% target yield with monthly dividends would you invest in it</a>?</li>
<li>During market downturns, investors are learning that unlike equities, these<a href="https://www.benzinga.com/money/connect-invest-real-estate-notes-y2"> high-yield real estate notes that pay 7.5% &#8211; 9% are protected by resilient assets, buffering against losses.</a></li>
</ul>
&#8220;These counties you identified could potentially experience superior housing performance following the election,&#8221; lead author Eren Cifci, assistant professor of finance at Austin Peay State University, told Realtor.com.
The pattern held regardless of political party. Areas supporting whichever nonincumbent candidate won the White House showed stronger price performance in subsequent years.
Federal spending often follows electoral shifts. &#8220;The rival party may recognize the critical role these counties played in securing their victory. Consequently, they might invest in these areas and work to improve living conditions to maintain voter support in future elections,&#8221; Cifci said.
Local engagement also drives growth. Communities voting for change often see increased civic participation, volunteerism and economic activity, which lift property values.
See Also: Unlock the hidden potential of commercial real estate —<a href="https://equitymultiple.com/benzinga?invite=benzinga&amp;utm_campaign=product-promotion-earn&amp;utm_source=yahooFinance&amp;utm_medium=affiliate&amp;utm_content=unlockboost-yahoo"> This platform allows individuals to invest in commercial real estate offering a 12% target yield with a bonus 1% return boost today!</a>
The research found no notable price impacts in counties flipping to incumbent winners or losing candidates. Cifci emphasized the findings indicate potential trends rather than guarantees.
Current market conditions vary widely among the 84 counties. Georgia&#8217;s Baldwin County saw November median list prices rise 53% year-over-year to $356,250, while Florida&#8217;s Miami-Dade County dropped 9.2% to $634,000.
The study primarily focused on how home prices, rather than the reverse, influence elections. Counties with strong price appreciation supported incumbents, while underperforming markets favored challengers.
&#8220;People feel more financially wealthy if they have a lot of housing equity,&#8221; said co-author Alan Tidwell, associate professor at the University of Alabama. &#8220;How financially wealthy they feel really impacts their sense of financial and economic well-being.&#8221;
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl-y2"> you can become an investor for $0.80 per share today. </a>Price swings <a href="https://www.benzinga.com/markets/24/12/42572520/2025-housing-market-looks-like-a-year-of-struggle-for-states-like-builders-now-hold-record-inventory?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=real_estate">show broad regional variation</a>. California&#8217;s Inyo County rose 4.9% to $562,450, while Montana&#8217;s Blaine County fell 43.79% to $120,000. Texas markets showed similar disparity – Culberson County jumped 75.71% to $264,450 as Hidalgo County declined 3.55% to $270,000.
The study tracked 84 counties across 27 states. Florida and Texas led with the most flipped counties at six and 10 respectively. California followed with seven counties switching their presidential preference.
Historical data suggests infrastructure spending increases often follow changes in voting patterns. Past election cycles saw upticks in road improvements, federal construction projects and housing development in areas that helped secure presidential victories.
Market analysts note the findings align with broader economic patterns linking political shifts to regional development. However, local market conditions, employment rates and population growth remain primary drivers of home values.
Read Next:
<ul>
<li>This Jeff Bezos-backed startup will allow you to <a href="https://arrivedhomes.go2cloud.org/aff_c?offer_id=15&amp;aff_id=1006&amp;aff_sub=yahoo&amp;aff_sub2=byerscta100">become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.</a></li>
<li>Commercial real estate has historically outperformed the stock market, and<a href="https://equitymultiple.com/benzinga?invite=benzinga&amp;utm_campaign=product-promotion-earn&amp;utm_source=yahooFinance&amp;utm_medium=affiliate&amp;utm_content=stockmarket-yahoo"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a></li>
</ul>

Real Estate

84 Counties That Flipped To Trump Could See Home Prices Rise Faster

PulteGroup's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHM#NYSE">PHM</a>) short percent of float has fallen 11.82% since its last report. The company recently reported that it has 4.59 million shares sold short, which is 2.91% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.5 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>PulteGroup Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735218012_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for PulteGroup has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing PulteGroup's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, PulteGroup's peer group average for short interest as a percentage of float is 10.07%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into PulteGroup's Recent Short Interest

This agreement provides Hoth with exclusive rights to a jointly owned patent portfolio co-developed by the VA and Emory University.
Under the terms of the agreement, Hoth Therapeutics will have exclusive rights to develop, market, and commercialize products and processes derived from the licensed patents. The VA and Emory University have granted Hoth this license to further develop the technology with the goal of ensuring the benefits of this innovation are accessible to the widest audience possible.
Hoth has also entered into an agreement to further protect its intellectual property by signing an LOI to acquire additional provisional patent protection for its lead therapeutic HT-001. The additional intellectual property expands HT-001's reach to other cancer therapeutics.

HOTH

Hoth Therapeutics Enters Exclusive Patent License Agreement With US Department Of Veterans Affairs

Morgan Stanley analyst Eric Serotta maintains Celsius Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) with a Equal-Weight and maintains $42 price target.

CELH

Morgan Stanley Maintains Equal-Weight on Celsius Holdings, Maintains $42 Price Target

Honda Motor shares are trading higher after the company recently announced it agreed to begin discussions and consideration toward a business integration with Nissan Motor.

Ginkgo Bioworks Holdings, Inc. (DNA) Q3 2024 Earnings Call Transcript

TD Cowen analyst Brendan Smith maintained a Buy rating on Ginkgo Bioworks Holdings (DNA – Research Report) today and set a price target of $10.00. ...

Positive Outlook for Ginkgo Bioworks: Strategic Developments and Financial Strength Bolster Buy Rating

Ginkgo Bioworks: Not Enough Progress

BTIG analyst Mark Massaro lowered the firm's price target on Ginkgo Bioworks (DNA) to $6 from $7 and keeps a Sell rating on the shares after its Q3...

Ginkgo Bioworks price target lowered to $6 from $7 at BTIG

Ginkgo Bioworks: Unproven Transition But 2025 Is Looking Better

In a report released yesterday, Tejas Savant from Morgan Stanley maintained a Hold rating on Ginkgo Bioworks Holdings (DNA – Research Report), with...

Ginkgo Bioworks Holdings: Hold Rating Amidst Revenue Growth and Restructuring Efforts

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q3 2024 Update

Ginkgo Bioworks (DNA) is down -8.3%, or -85c to $9.47. Published first on TheFly – the ultimate source for real-time, market-moving breaking financ...

Ginkgo Bioworks falls -8.3%

Ginkgo Bioworks eligible for $9.4M in partnership for bioelectronic devices

Ginkgo Bioworks (DNA) is down -7.7%, or -78c to $9.30. Published first on TheFly – the ultimate source for real-time, market-moving breaking financ...

Ginkgo Bioworks falls -7.7%

ACHC

ADBE

ADPT

AMZN

AVGO

BBIO

BMRN

CBRE

DASH

DDOG

DLTR

DNABW

EWTX

FERG

FLUT

INBX

ISRG

MSFT

NAMS

NFLX

ORIC

PEPG

PHVS

ROIV

RPRX

SPOT

TEAM

TMUS

TRVI

VKTX

WDAY

Press Releases

Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement

Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology

Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology

Legal

Pomerantz LLP Announces that this is a Reminder of a Proposed Class Action Settlement on Behalf of Purchasers of Ginkgo Bioworks Holdings, Inc. Common Stock - DNA

NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture

Finding Family DNA Podcast Series Wins Gold!

Commodities

Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation

Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing

Earnings

Ginkgo Bioworks Reports Third Quarter 2024 Financial Results

Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program

Comments

Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings (DNA) 옵션

Ginkgo Bioworks Holdings (NYSE:DNA) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌